Merck Warns
Pharmaceutical giant Merck (MRK) - Get Report announced that slower-than-expected sales for arthritis fighting drug Vioxx and currency problems would result in lower-than-expected second-quarter and fiscal 2001 earnings.
The company now expects second-quarter earnings per share to come in between 77 cents and 79 cents, with 2001 EPS between $3.12 and $3.18. That's lower than the 81 cents a share expected by analysts for the second quarter and the $3.20 a share for 2001.
The stock is off 4.3% in preopen trading.
Loading ...